InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.34
(
0.61%
)
Bitcoin
63,704.87
(
0.13%
)
Post# of 27731
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

$Pistol Pete$

Send PM Follow Ignore
Followers 2540
Posts 250759
Boards Moderated 35
Alias Born 05/06/2014

$Pistol Pete$

Re: None

Wednesday, 03/29/2017 1:49:44 AM

Wednesday, March 29, 2017 1:49:44 AM

Post# of 27731
$PMCB PharmaCyte Biotech Discusses Patient Enrollment and TD2’s Role in Upcoming Clinical Trial PMCB

http://globenewswire.com/news-release/2017/02/21/925912/0/en/PharmaCyte-Biotech-Discusses-Patient-Enrollment-and-TD2-s-Role-in-Upcoming-Clinical-Trial.html


Go $PMCB

investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up